EMCDDA Home
  • EN

Table INF-0. Bibliographic references

Part (ii) References for notifications data

CountryReference NoReference
International0no bibliographic reference is existing for this particular study
99National Focal Point, unpublished data
Belgium26Ducoffre G. (2008). Surveillance des Maladies Infectieuses par un Réseau de Laboratoires de Microbiologie 2007. Tendances Epidémiologiques 1983 - 2006. Institut Scientifique de Santé Publique, Section Epidémiologie.Available : http://www.iph.fgov.be/epidemio/epien/index8.htm
Bulgaria1Tomov N. National Centre for Addictions.
1bAnnual Report of the NFP on the state of drug related problems in Bulgaria - 2005, National Focal Point, Sofia, 2005
Czech Republic6Beneš, J. and Cástková, J. (2004) Viral Hepatits 1995 – 2003 – EPIDAT. Prague: National Institute of Public Health.)
9Mravcik,V. et. al. (2005), Annual Report: The Czech Republic-2004 Drug Situation, Prague: Office of he Government of the Czech Republic.
11Mravcík, V., Petrošová, B., Zábranský, T., Coufalová, M. and Rehák, V. (2006) Výskyt VHC u injekcních uživatelu drog. Praha: Úrad vlády CR.
15Epidat, The Reporting Systém of Notifiable Disease, 2006, NIPH, Czech Republic, Prague
16Benes, J. (2008) Viral Hepatits 1996 - 2007 - EPIDAT. Prague: National Institute of Public Health. Unpublished
17Epidat, The Reporting System of Notifiable Diseases, 2008, NIPH, Czech Republic, Prague
18Epidat, The Reporting System of Notifiable Disease, 2007, NIPH, Czech Republic, Prague
21Epidat, The Reporting System of Notifiable Diseases, 2009, NIPH, Czech Republic, Prague
22Benes, J. (2009) Viral Hepatits 1996 - 2008 - EPIDAT. Prague: National Institute of Public Health. Unpublished
29Benes, J. (2010) Viral Hepatits 1996 - 2009 - EPIDAT. Prague: National Institute of Public Health. Unpublished
30Epidat, The Reporting System of Notifiable Diseases, 2010, NIPH, Czech Republic, Prague
33Benes, J. (2011) Viral Hepatits 1996 - 2010 - EPIDAT. Prague: National Institute of Public Health. Unpublished
34Epidat, The Reporting System of Notifiable Diseases, 2012, NIPH, Czech Republic, Prague
35Benes, J. (2012) Viral Hepatits 1996 - 2011 - EPIDAT. Prague: National Institute of Public Health. Unpublished
Denmark4E. Smith. Statens Serum Institut.
Germany20Die Hepatitiden B und C bei drogenabhängigen Patienten: eine epidemiologische Studie. Suchttherapie, Supp. 2002; 3:51-52 / personal information
Estonia1Kutsar K, Health Protection Inspectorate, Tallinn.
6Health Protection Inspectorate.(2009). Notified cases of hepatitis C and B in injecting drug users. (Personal communication, Jevgenia Epštein).
7Health Board by EDMC (Estonian governmental health authority) using ST9 part 4
Ireland13Smyth B, O'Connor JJ, Barry J, Keenan E. Retrospective cohort study examining incidence of HIV and Hepatitis C infection among injecting drug users in Dublin. Journal of Epidemiology and Community Health 2003;57:310-311.
14Unpublished data provided by the Health Protection Surveillance Centre. Please see Ireland National Report for 2009.
15Unpublished data provided by the Health Protection Surveillance Centre. Please see Ireland National Report for 2010.
16Unpublished data provided by the Health Protection Surveillance Centre. Please see Ireland National Report for 2012.
France20Lucidarme D, Bruandet A, Ilef D, Harbonnier J, Jacob C, Decoster A, Delamare C, Cyran C, Van Hoenacker AF, Fremaux D, Josse P, Emmanuelli J, Le Strat Y, Desenclos JC, Filoche B.: Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France. Epidemiol Infect. 2004 Aug;132(4):699-708.
22Cadet-Tairou A and al, Phénomènes émergents liés aux drogues en 2006, huitième édition du rapport national du dispositif TREND, Saint Denis, OFDT, Saint Denis, 2008, 189 p
Italy28Istituto Superior di Sanità, Sistema epidemiologico integrata dell’epatite virale acuta (SEIEVA)
Latvia3Perevoscikovs J. (2003). State Public Health Agency. Epidemiologijas biletens [Bulletin of Epidemiology] [in Latvian], 84 (720)
8Bormane A., Lucenko I., Perevoscikovs J. (2004). “Communicable disease surveillance, prevention and control in Latvia”, Euro Surveill. 2004;8(25):pii=2487 [online]. Available: http://www.eurosurveillance.org/ew/2004/040617.asp#1 [accessed 5 May 2011]
9Public Health Agency (2008), unpublished data.
13Infectology Center of Latvia (2009), unpublished data.
19Data provided by Infectology Center of Latvia. Unpublished data, 2011.
20Data provided by Infectology Center of Latvia. Unpublished data, 2012.
Lithuania4Bagdonaite J., Centre for Communicable Diseases Prevention and Control, Vilnius, Lithuania (unpublished data)
9Centre for Communicable Diseases Prevention and Control (unpublished data)
15Centre for Communicable Diseases and AIDS
Luxembourg1dOriger A., Ministry of Health – Luxembourg
5Origer A. (2006). National report on the state of the drugs problem - RELIS2005, NFP - CES/CRP-Sante, Luxembourg
9Origer, A. (2009) Rapport national sur l'Etat du Phenomene des Drogues et des Toxicomanies au Grand Duche du Luxembourg 2008 (RELIS), PF OEDT/CES CRP-SANTE, Luxembourg.
10Origer, A. (2010) Rapport national sur l'Etat du Phenomene des Drogues et des Toxicomanies au Grand Duche du Luxembourg 2008 (RELIS), PF OEDT/CES CRP-SANTE, Luxembourg.
11Origer, A.(2011) Rapport National sur l'état du phénomène des drogues et des toxicomanies au Grand-Duché du Luxembourg, 2010 (RELIS), PF-OEDT/CRP-Santé, Luxembourg
12Origer, A. (2012). Rapport National sur l'état du phénomène de la Drogue au Grand-Duché de Luxembourg, RELIS 2011, NFP-CRP-santé, Luxembourg
Hungary1Csohán Á. National Center for Epidemiology, Department for Epidemiology, Budapest. (personal comm.)
6National Center for Epidemiology, Department for Epidemiology, Budapest 2006 Csohán, Ágnes (unpublished data)
10Csohán Á. National Center for Epidemiology, Department for Epidemiology, Budapest (personal comm.)
11Agnes Csohan MD. National Center for Epidemiology, Department for Epidemiology. Budapest. 2008.(unpublished results)
12Csohan, A., Dudas, M., Gyori, Z., Minarovits, J., Rusvai, E. (2008): Official report of the examination on prevalence regarding infections related to IV drug use in 2006-2007. unpublished report.
13Agnes Csohan MD. National Center for Epidemiology, Department for Epidemiology. Budapest. 2008.(unpublished results)
14Agnes Csohan MD. National Center for Epidemiology, Department for Epidemiology. Budapest. 2009.(unpublished results)
22Agnes Csohan MD. National Center for Epidemiology, Department for Epidemiology. Budapest. 2010.(unpublished results)
24Agnes Csohan MD. National Center for Epidemiology, Department for Epidemiology. Budapest. 2011.(unpublished results)
25Agnes Csohan MD. National Center for Epidemiology, Department for Epidemiology. Budapest. 2012.(unpublished results)
Malta42005 notifications to the Disease Surveillance Unit.
62006 Disease Surveillance Unit Notifications
8SMOPU Data Files
9SMOPU (Guardamangia,2012 (unpublished results)
10Health Promotion and Disease Prevention, Msida, 2012 (unpublished results)
Netherlands19Op de Coul E., National Institute for Public Health and the Environment (RIVM), Bilthoven. (unpublished data).
20Op de Coul E., Bosman A., van de Laar M. Aangiftesysteem voor HCV moet beter. Surveillance van hepatitis C in Nederland, 1992-2002. Infectieziekten Bulletin 2003, 14(9): 323-328.
23Koedijk, F., Op de Coul, E.L.M., Van de Laar, M. Aangifte acute HBV in 2003 (in progress, Infectieziekten Bulletin 2004); Koedijk, F., Op de Coul, E.L.M., Van de Laar, M. Chronische hepatitis B infecties in Nederland, 2001-2003 (in progress, Infectieziekten Bulletin 2004)
24Health Inspectorate/RIVM
25F. Koedijk, E.L.M. Op de Coul, M. van de Laar. Aangifte acute HBV in 2004 (in progress, Infectieziekten Bulletin 2005)
26GGD Amsterdam 2006 (unpublished data).
28Koedijk FDH, Op de Coul, ELM, Van der Sande MAB, Hahné S. Aangifte acute hepatitis B in 2006: Aantal nieuwe infecties daalt met 20%. Infectieziekten Bulletin (In Press)
29Koedijk FDM et al. (2008). Incidentie en moleculaire epidemiologie hepatitis B in Nederland, 2004-2007. RIVM, Bilthoven.
30Van den Broek IVF, Koedijk FDH, Van Veen MG, OP de Coul ELM, Van Sighem N, Van der Sande MAB (2008). Sexually transmitted infection, including HIV, in the Netherlands in 2007. RIVM, Bilthoven.
31National Focal Point, unpublished data
32National Institute of Public Health and the Environment (RIVM). Bilthoven. (unpublished data)
37Vriend HJ, Koedijk FDH, van den Broek IVF et al. Sexually transmitted Infections, including HIV, in the Netherlands in 2009. Bilthoven: Centre for Infectious Disease Control - National Institute for Public Health and the Environment (RIVM) 2010
38H.J. Vriend, F.D.H. Koedijk, I.V.F. van den Broek , M.G. van Veen, E.L.M. Op de Coul, A.I. van Sighem, R.A. Verheij, M.A.B. van der Sande. Sexually Transmitted Infections in the Netherlands in 2010. RIVM rapport 210261009/2011.
39S.C.M. Trienekens, F.D.H. Koedijk, I.V.F. van den Broek, H.J. Vriend, E.L.M. Op de Coul, M.G. van Veen, A.I. van Sighem, I. Stirbu-Wagner, M.A.B. van der Sande. Sexually Transmitted Infections in the Netherlands in 2011. RIVM report 201051001/2012
Poland3National Focal Point, pers. comm. 2004.
8National Institute of Public Health - National Institute of Hygiene (2008) Warsaw, Poland (unpublished results).
13National Institute of Public Health - National Institute of Hygiene http://www.pzh.gov.pl/page/
14Stepien, M., Czarkowski, MP. (2010) “Hepatitis B in Poland in 2008” Przeglad Epidemiologiczny 2010; vol.64: p.239 - 244.
15Stepien, M., Rosinska, M. (2010) “Hepatitis C in Poland in 2008” Przeglad Epidemiologiczny 2010; vol.64: p.245 - 250.
16Department of Epidemiology of the National Institute of Public Health - National Institute of Hygiene and Department of Communicable Disease Control of the Chief Sanitary Inspectorate. Biweekly Epidemiological Reports [online]. Available: http://www.pzh.gov.pl/oldpage/epimeld/2009/index_mp.html [accessed 21.09.2010]
17Czarkowski, MP., Cielebak, E., Kondej, B., Staszewska, E. (2009) “Infectious diseases and poisonings in Poland in 2008 [online]”. National Institute of Public Health - National Institute of Hygiene and the Chief Sanitary Inspectorate. Warsaw. Available: http://www.pzh.gov.pl/oldpage/epimeld/2008/Ch_2008.pdf [accessed 21.09.2010]
18Rosinska M, Stepien M. [Hepatitic C in Poland in 2009]. Przegl Epidemiol 2011; 65: 265 - 270.
19Stepien M, Czarkowski MP. [Hepatitis B in Poland in 2009]. Przegl Epidemiol 2011; 65: 259-264.
20Rosinska M, Radziszewski F, Stepien M. [Hepatitic C in Poland in 2010]. Przegl Epidemiol 2012; 66: 287 - 292.
21Stepien, M., Czarkowski, MP. “Hepatitis B in Poland in 2010” Przeglad Epidemiologiczny 2012; vol.66: p.277 - 286.
Slovenia1Institute of Public Health of the Republic of Slovenia, Ljubljana.
7National Institute of Public Health (2010). Epidemiological surveillance of communicable disease in year 2009. IVZ, Ljubljana (in Slovene).Available: http://www.ivz.si/?ni=105&pi=5&_5_Filename=2491.pdf&_5_MediaId=2491&_5_AutoResize=false&pl=105-5.3.
Slovakia1Okruhlica, L., Klempova, D.: Hodnocení programu vakcinace proti hepatitide typu B u uživatelú drog v Bratislave (Evaluation of a Hepatitis B Vaccination Programme among Drug Users in Bratislava), Adiktologie, 2002, 2, p.11-18.
4Okruhlica, L., Centre for Treatment of Drug Dependencies. Bratislava.
5Okruhlica, L., Gazdik, F., Klempova, D.: Hepatitída C a aktuálne súvislosti s odborom drogových závislostí, Alkoholizmus a drogové závislosti (Protialkoholický obzor), 2003, 38, p.75-82.
8Annual reports of epidemiology departements from Regional offices of public health in Slovakia
9National Focal Point, unpublished data (source charged to collect data: Regional Authority of Public Health)
11Annual report from all offices of regional public health in Slovakia.
Finland1aHolmström P. National Public Health Institute (KTL) Department of Infectious Diseases Epidemiology (unpublished data).
4National Research and Development Centre for Welfare and Health (STAKES). Private practioner and heroin addicts: A case study on the impact of medical outpatient care on criminal activities. STAKES. Helsinki, 1998
5National Focal Point, pers. comm. 2004.
6Brummer Korvenkontio H. National Public Health Institute (KTL) Department of Infectious Diseases Epidemiology (unpublished data).
9National Focal Point (unpublished data).
Sweden3Swedish Institute for Infectious Disease Control
11Swedish Institute for Infectious Disease Control. Blodsmitta [online]. Available: http://www.smi.se/statistik/sok-pa-sjukdomskategori/?c=241 [accessed April 2009]
12Anna Mia Ekstrom, Karolinska Institutet, Stockholm, 2010 (unpublished results).
14Smittskyddsinstitutet (Swedish Institute for Communicable Disease Control)
United Kingdom22Surveillance of known hepatitis C antibody cases in Scotland: Results to 30th June 2002. SCIEH Weekly Report 2003; 37(15): 96-101.
Norway4Marte Ødegård Lund, SIRUS – Norwegian Institute for Alcohol and Drug Research, unpublished data.
7Norwegian Institute of Public Health, Department of Infectious Disease Epidemiology. Oslo.
13Surveillance system for Communicable Diseases (MSIS(online). Norwegian Institute of Public Health Available: http://www.msis.no/ (accessed 22.09.2008)
14Norwegian Institute of Public Health. Surveillance of Communicable Diseases and Nosocomial Infections in Norway 2006. Available: http://www.fhi.no/eway/default.aspx?pid=233&trg=MainArea_5661&MainArea_5661=5631:0:15,2369:1:0:0:::0:0 (accessed 22.09.2008)
22Surveillance system for Communicable Diseases (MSIS(online). Norwegian Institute of Public Health Available: http://www.msis.no/ (accessed 24.09.2009)
24Norwegian Institute of Public Health. Surveillance of Communicable Diseases and Nosocomial Infections in Norway 2006. Available: http://www.fhi.no/eway/default.aspx?pid=233&trg=MainArea_5661&MainArea_5661=5631:0:15,2369:1:0:0:::0:0 (accessed 14.10.2010)
26Surveillance system for Communicable Diseases (MSIS(online). Norwegian Institute of Public Health Available: http://www.msis.no/ (accessed 24.09.2011)
27Surveillance system for Communicable Diseases (MSIS(online). Norwegian Institute of Public Health Available: http://www.msis.no/ (accessed 01.10.2012)
 

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013